• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Global Med Technologies(R), Inc.'s CEO to Present at the Third Annual Maxim Group Growth Conference

Posted on: Friday, 25 September 2009, 08:00 CDT

DENVER, Sept. 25 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, will present at the Third Annual Maxim Group Growth Conference. Mick Ruxin, M.D., Chairman and CEO, is scheduled to present on Tuesday, September 29, 2009, at 9:30 a.m. Eastern in the Imperial Room of the Grand Hyatt Hotel in New York.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO

Dr. Ruxin will give a 25-minute presentation regarding Global Med's business and discuss its unique value proposition, latest product developments, including the verIDhemos system, which is Global Med's recently announced innovative transfusion safety RFID product (not for sale in the U.S.), as well as the Company's financial performance and prospects. A question and answer session will follow the presentation.

The presentation will be Webcast live and may be accessed by visiting: http://www.wsw.com/webcast/maxim2/glob.ob/. A replay of the presentation will also be available on Global Med's Website at www.globalmedtech.com for 30 days following the presentation.

About Global Med Technologies(R), Inc.

Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.

Global Med's domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(R), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

SOURCE Global Med Technologies, Inc.

Source: PR Newswire

More News in this Category